FindTrial
Sign In

Brain Metastasis Development Mechanism in BCBM Patients

Evaluation of Brain Metastasis Development Mechanism in Patients With Breast Cancer With Brain Metastasis(BCBM)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06330870
Enrollment
30
Registered
2024-03-26
Start date
2023-04-06
Completion date
2027-12-31
Last updated
2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Metastasis, Breast Cancer

Brief summary

This study is the experimental study for brain metastasis development mechanism in patients with breast cancer with brain metastasis

Interventions

PROCEDUREWGS/TME evaluation

WGS/TME evaluation with blood and brain metastasis tissue during brain metastasis curative surgery

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Breast cancer * Brain metastasis curative surgery patient

Exclusion criteria

* Gamma Knife surgery patient

Design outcomes

Primary

MeasureTime frameDescription
Intracranial disease free survivalMonthsTime to new brain metastasis or brain metastasis progression from the brain surgery

Countries

South Korea

Contacts

Primary ContactJi-Yeon Kim
jyeon25@skku.edu82-2-3410-3459
Backup ContactMee Ryung Hong
ring7629@naver.com82-2-2148-7147

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026